Skip to main content
. 2016 Sep 2;5(10):e1221555. doi: 10.1080/2162402X.2016.1221555

Figure 2.

Figure 2.

Frequency of PD-1 methylation (mPD-1) in 498 prostate carcinoma samples. PD-1 promoter methylation analysis revealed a symmetric, almost Gaussian distribution (black line) covering a broad spectrum of values (18–88%) with a bifurcation at 55%. An optimal mPD-1 cut-off was elaborated by an iterative approach (57.50%) stratifying patients into PD-1 hyper- (mPD-1high) and hypomethylated (mPD-1low) cases.